mint Analytics: Real-time data visualization and analysis in clinical trials with imaging endpoints

We talked to PD Dr. Wolfgang G. Kunz, Head of Oncological Imaging and of the Oncological Study Center at the Ludwig Maximilians University Hospital Munich, about his experience with mint Analytics, an extensive add-on of the leading radiological platform mint Lesion™.

Next to the data visualization of multiple trials, PD Dr. Kunz and his team use mint Analytics for quality control of trial site reads and for sharing the current status of trial results with oncological PIs, which provides them with an estimate of what responses can be clinically expected. PD Dr. Kunz also provides an insight into how mint Analytics has the ability to open up new avenues of single and multicentric research projects and how this can benefit other radiologists, oncologists, imaging CROs as well as sponsors.

Related Resources

Related Resources

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

A picture of a person looking at a brain scan and the interface of mint Lesion™  on a computer

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…

A picture of radiologists looking at a screen showing the restaging of the HNSCC

Study Highlights the Potential of Radiomics in Medical Intervention

A recent study conducted by the Medical University of Innsbruck highlights the potential of radiomics in exploring the impacts of Radiochemotherapy…